BeiGene vs OneThree Biotech
BeiGene vs OneThree Biotech, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BeiGene is on 64/100 and OneThree Biotech on 45/100.
Where each one leads
BeiGene
- our overall score: 64/100 against 45/100
- agent readiness: 50/100 against 22/100
- domain rating: 68/100 against 16/100
- funding raised: $358M against $2.8M
OneThree Biotech
Leads on none of the measures we hold for both companies.
At a glance
| Measure | BeiGene | OneThree Biotech |
|---|---|---|
| What it is | A global oncology company developing and commercializing innovative cancer treatments. | AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, HealthTech, Drug Discovery, AI-Driven Protein Design |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2010 | 2018 |
| Headquarters | Cambridge, United States | New York City, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | BeiGene | OneThree Biotech |
|---|---|---|
| Open roles | 100 | Not published |
| Total funding | $358M | $2.8M |
| Latest round | Secondary Offering | Seed |
| Valuation | $15B | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BeiGene | OneThree Biotech |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 64/100 | 45/100 |
| Traction | 40/100 | 32/100 |
| Team | 30/100 | 70/100 |
| Search visibility | 17/100 | 14/100 |
| Quality | 88/100 | 50/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 68/100 | 16/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BeiGene | OneThree Biotech |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Not detected |
BeiGene vs OneThree Biotech: common questions
Which is better, BeiGene or OneThree Biotech?
On our 0-100 score BeiGene rates higher (64/100 against 45/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do BeiGene and OneThree Biotech compare on the numbers?
BeiGene leads on our overall score (64/100 against 45/100), agent readiness (50/100 against 22/100), domain rating (68/100 against 16/100), funding raised ($358M against $2.8M).
Read the full BeiGene review and pricing or the OneThree Biotech review and pricing. You can also browse other BeiGene alternatives we track.